“Michael Hearne”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  2/26/24  as  ↓Signatory

        

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Michael Hearne” has been a Signatory for/with  9  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/26/24		MA	Theseus Pharmaceuticals, Inc.	4	15-12G	—
1/10/24		CA	Concentra Merger Sub II, Inc.	1	SC TO-T	MA	Theseus Pharmaceuticals, Inc.
7/17/23		MA	Dianthus Therapeutics, Inc./DE	1	S-4/A	—
5/15/23		MA	Jounce Therapeutics, Inc.	12	15-12G	—
4/6/23		CA	Concentra Merger Sub, Inc.	1	SC TO-T	MA	Jounce Therapeutics, Inc.
2/24/23			ASLAN Pharmaceuticals Ltd.	1	6-K	—
8/15/22		MA	La Jolla Pharmaceutical Co.	28	10-Q	—
2/7/22		NY	Odonate Therapeutics, Inc.	25	15-12B	—
8/24/20		MA	Tetraphase Pharmaceuticals Inc.	14	S-8 POS	—

“Michael Hearne” has/had a Signatory interest in  2  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
1/10/24		MA	Theseus Pharmaceuticals, Inc.	1	SC TO-T	CA	Concentra Merger Sub II, Inc.
5/4/23		MA	Jounce Therapeutics, Inc.	2	SC 14D9/A	MA	Jounce Therapeutics, Inc.